NCT00003388View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

July 26, 1999

Primary Completion Date

April 30, 2003

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

methotrexate

DRUG

pegylated liposomal doxorubicin hydrochloride

DRUG

prednisone

DRUG

vincristine sulfate

RADIATION

radiation therapy

Trial Locations (5)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

10466

MBCCOP-Our Lady of Mercy Cancer Center, The Bronx

94304

Veterans Affairs Medical Center - Palo Alto, Palo Alto

94305-5408

Stanford University Medical Center, Stanford

08861

Raritan Bay Medical Center, Perth Amboy

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003388 - Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | Biotech Hunter | Biotech Hunter